Drugs / Licensed seasonal influenza vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03163342 | May → Nov 2017 | influenza | Altimmune, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Licensed seasonal influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03163342 ↗ |
| Modality | Vaccine | “FDA approved 2016-2017 quadrivalent influenza vaccine” NCT03163342 ↗ |
| Route | Intramuscular | “single intramuscular injection of the FDA approved 2016-2017 quadrivalent influenza vaccine” NCT03163342 ↗ |